Fetal Oropharyngeal and Neck Tumors: Determination of the Need for Ex-Utero Intrapartum Treatment Procedure

Year 2015, Volume: 32 Issue: 2, 221 - 225, 01.04.2015

Fatma Tuncay Özgünen Ümran Küçükgöz Güleç Ümran Küçükgöz Güleç İsmail Cüneyt Evrüke Süleyman Cansun Demir Selim Büyükkurt Hacer Yapıcıoğlu Serdar İskit

Abstract

Background: The aim of this study was to assess the ex-utero intrapartum therapy (EXIT) applied to 3 of the 7 cases with oropharyngeal or neck masses and review the indicators of the need for an EXIT procedure. Case Report: Prenatal presentation, size and localization of the masses, existence of fetal hydrops and associated findings such as polyhydramnios, intraoperative managements, complications, and maternal and neonatal outcomes were evaluated through a retrospective analysis. Four cases had neck masses and three cases had oropharyngeal masses. Prenatal sonography was used as the main diagnostic tool for all patients. The median gestational age was 34.5 weeks at the time of diagnosis and 36 weeks at delivery. Polyhydramnios was observed in three of the seven cases and they were delivered prematurely. Interventions such as endotracheal intubation or tracheostomy were performed to provide patency of the airway during delivery by the EXIT procedure in three cases. Hemangioma was found in two cases, teratoma in two cases, lymphangioma in two cases and hamartoma in one case following pathological examination of the masses. Conclusion: The localization of mass, its characteristics, invasion (if it exists), and relation to the airway are the main factors used to determine the need for EXIT. The presence of polyhydramnios may be an important indicator to predict both the need for EXIT and fetal outcomes.

Keywords

Ex-utero intrapartum therapy (EXIT), fetal oropharyngeal tumors, fetal neck tumors, polyhydramnios, ultrasonography

References

• 1. Hirose S, Harrison MR. The ex utero intrapartum treatment (EXIT) procedure. Semin Fetal Neonatal Med 2003;8:207-14. [CrossRef]
• 2. Marwan A, Crombleholme TM. The EXIT procedure: principles, pitfalls, and progress. Semin Pediatr Surg 2006;15:107-15. [CrossRef]
• 3. Olutoye OO, Olutoye OA. EXIT procedure for fetal neck masses. Curr Opin Pediatr 2012;24:386-93. [CrossRef]
• 4. Liechty KW. Ex-utero intrapartum therapy. Semin Fetal Neonatal Med 2010;15:34-9. [CrossRef]
• 5. Kalache KD, Masturzo B, Pierro A, Peebles D, Chitty LS. Prenatal evaluation of fetal neck masses in preparation for the EXIT procedure: The value of pulmonary Doppler Ultrasonography (PDU). Prenat Diagn 2001;21:308-10. [CrossRef]
• 6. Moldenhauer JS. Ex utero intrapartum therapy. Semin Pediatr Surg 2013;22:44-9. [CrossRef]
• 7. Lazar DA, Olutoye OO, Moise KJ Jr, Ivey RT, Johnson A, Ayres N, et al. Ex- utero intrapartum treatment procedure for giant neck massesfetal and maternal outcomes. J Ped Surg 2011;46:817-22. [CrossRef]
• 8. Awonuga AO, Bell J, Vallecilla D, Ray C, Yingling D, Helfgott A. Antenatal diagnosis and perinatal management of extremely giant fetal cervicopharyngeal teratoma resulting in impossible fetal intubation: a case report. Fetal Diagn Ther 2009; 25:340-2. [CrossRef]
• 9. Butwick A, Aleshi P, Yamout I. Obstetric hemorrhage during an exit procedure for severe fetal airway obstruction. J Can Anesth 2009;56:437-42. [CrossRef]
• 10. Abraham RJ, Sau A, Maxwell D. A review of the EXIT (Ex utero Intrapartum Treatment) procedure. J Obstet Gynaecol 2010;30:1-5. [CrossRef]